Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Alithea Genomics SA

History from 20 May 2020

UID
CHE-218.846.606
Legal form
AG
Canton
VD
Founded
20 May 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 233k
58k117k175k233k24 May 2022 · CHF 144k5 Mar 2024 · CHF 202k18 Feb 2026 · CHF 233kRound announced 4 Mar 202620222023202420252026
  • shares
  • all shares
  • de Catégorie Seed, privilégiées quant au produit de liquidation
  • round announced

Record

  1. Company formed

    Founded 20 May 2020

    SHAB HR01-1004902077 ↗
  2. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    100’000 → 144’294
    Shares
    100’000 → 144’294
    New shares, % of post-step shares
    30.7% (44’294 new)
    Share classes
    100’000 × CHF 1 · 44’294 × CHF 1 de Catégorie Seed, privilégiées quant au produit de liquidation
    SHAB HR02-1005481110 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    144’294 → 201’804
    Shares
    144’294 → 201’804
    New shares, % of post-step shares
    28.5% (57’510 new)
    Share classes
    100’000 × CHF 1 · 101’804 × CHF 1 de Catégorie Seed, privilégiées quant au produit de liquidation
    SHAB HR02-1005977985 ↗
  4. Capital increase

    Confirmed round

    Paid in cash

    Nominal capital
    201’804 → 233’103
    Shares
    201’804 → 201’804
    New shares, % of post-step shares
    — (no new shares)
    Share classes
    100’000 × CHF 1 · 101’804 × CHF 1 de Catégorie Seed, privilégiées quant au produit de liquidation
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006573579 ↗
  5. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

Published by 8 Oct 2026